Page 80 - Vitamin D and Cancer

3 Anti-inflammatory Activity of Calcitriol in Cancer 67

53. Rubio J, Ramos D, Lopez-Guerrero JA, Iborra I, Collado A, Solsona E, Almenar S,
Llombart-Bosch A (2005) Immunohistochemical Expression of Ki-67 Antigen, Cox-2 and
Bax/Bcl-2 in Prostate Cancer; Prognostic Value in Biopsies and Radical Prostatectomy
Specimens. Eur Urol 31:31
54. Cohen BL, Gomez P, Omori Y, Duncan RC, Civantos F, Soloway MS, Lokeshwar VB,
Lokeshwar BL (2006) Cyclooxygenase-2 (cox-2) expression is an independent predictor of
prostate cancer recurrence. Int J Cancer 119(5):1082–1087
55. Simpson ER, Clyne C, Rubin G, Boon WC, Robertson K, Britt K, Speed C, Jones M (2002)
Aromatase–a brief overview. Annu Rev Physiol 64:93–127
56. Brodie AM, Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, DeJong PC, Blankenstein
MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH,
Thijssen JH (2001) Aromatase and COX-2 expression in human breast cancers. J Steroid
Biochem Mol Biol 79(1–5):41–47
57. Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM (1999)
Correlation of aromatase and cyclooxygenase gene expression in human breast cancer speci-
mens. Cancer Lett 140(1–2):27–35
58. Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ (2004) COX-2 expression is associated
with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 90(2):423–429
59. Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, Joensuu H, Isola J
(2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.
Cancer Res 62(3):632–635
60. Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ (2002) Cyclooxygenase-2 is overex-
pressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.
J Biol Chem 277(21):18649–18657
61. Wulfing P, Diallo R, Muller C, Wulfing C, Poremba C, Heinecke A, Rody A, Greb RR,
Bocker W, Kiesel L (2003) Analysis of cyclooxygenase-2 expression in human breast can-
cer: high throughput tissue microarray analysis. J Cancer Res Clin Oncol 129(7):375–382
62. Denkert C, Winzer KJ, Muller BM, Weichert W, Pest S, Kobel M, Kristiansen G, Reles A,
Siegert A, Guski H, Hauptmann S (2003) Elevated expression of cyclooxygenase-2 is a nega-
tive prognostic factor for disease free survival and overall survival in patients with breast
carcinoma. Cancer 97(12):2978–2987
63. Sinicrope FA, Gill S (2004) Role of cyclooxygenase-2 in colorectal cancer. Cancer
Metastasis Rev 23(1–2):63–75
64. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM,
Evans JF, Taketo MM (1996) Suppression of intestinal polyposis in Apc delta716 knockout
mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87(5):803–809
65. Humar B, Giovanoli O, Wolf A, Attenhofer M, Bendik I, Meier R, Muller H, Dobbie Z
(2000) Germline alterations in the cyclooxygenase-2 gene are not associated with the devel-
opment of extracolonic manifestations in a large swiss familial adenomatous polyposis kin-
dred. Int J Cancer 87(6):812–817
66. Khan KN, Masferrer JL, Woerner BM, Soslow R, Koki AT (2001) Enhanced cyclooxyge-
nase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Scand J Gastroenterol 36(8):865–869
67. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB (2004) The role of inflammation in
the pathogenesis of prostate cancer. J Urol 172(5 Pt 2):S6–S11, discussion S-2
68. Wang W, Bergh A, Damber JE (2005) Cyclooxygenase-2 expression correlates with local
chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer
Res 11(9):3250–3256
69. Bamba H, Ota S, Kato A, Adachi A, Itoyama S, Matsuzaki F (1999) High expression of
cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 83(4):470–475
70. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC,
Guillou PJ, Markham AF, Coletta PL, Hull MA (2000) Localization of cyclooxygenase-2 in
human sporadic colorectal adenomas. Am J Pathol 156(2):545–553